Antimalarials may reduce cancer risk in patients with systemic lupus erythematosus: a systematic review and meta-analysis of prospective studies

OBJECTIVE: To investigate the effect of antimalarials on cancer risk in patients with systemic lupus erythematosus (SLE). METHODS: PubMed, EMBASE, Web of Science, and the Cochrane Library were searched from their inception to October 3, 2020. Relative risk (RR) with 95% confidence intervals (CI) was...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xian-Bao, Cao, Nv-Wei, Chu, Xiu-Jie, Zhou, Hao-Yue, Wang, Hua, Yu, Si-Jie, Ye, Dong-Qing, Li, Bao-Zhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462850/
https://www.ncbi.nlm.nih.gov/pubmed/34553648
http://dx.doi.org/10.1080/07853890.2021.1981547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462850/
https://www.ncbi.nlm.nih.gov/pubmed/34553648
http://dx.doi.org/10.1080/07853890.2021.1981547

Ejemplares similares